Genetic influences on right ventricular systolic pressure (RVSP) in chronic obstructive pulmonary disease (COPD)

BMC Pulmonary Medicine

Volumn 12, Issue , 2012, Pages

  Shaw, Janet G ^a,b   Dent, Annette G ^a,b   Passmore, Linda H ^a   Burstow, Darryl J ^a   Bowman, Rayleen V ^a,b   Zimmerman, Paul V ^a,b   Fong, Kwun M ^a,b   Yang, Ian A ^a,b  

^a THE PRINCE CHARLES HOSPITAL   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

COPD; Genetic polymorphism; Pulmonary hypertension

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENDOTHELIN 1; PROSTACYCLIN SYNTHASE; SEROTONIN TRANSPORTER; VASCULOTROPIN A;

ADULT; AGED; ALLELE; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; FEMALE; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HEART RIGHT VENTRICLE SYSTOLIC PRESSURE; HUMAN; HYPOXEMIA; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; PREDICTION; SINGLE NUCLEOTIDE POLYMORPHISM; SPIROMETRY; SYSTOLIC BLOOD PRESSURE; TRANSTHORACIC ECHOCARDIOGRAPHY;

AGED; COHORT STUDIES; FEMALE; FORCED EXPIRATORY VOLUME; GENETIC MARKERS; GENOTYPE; GENOTYPING TECHNIQUES; HUMANS; HYPERTENSION, PULMONARY; LINEAR MODELS; MALE; MINISATELLITE REPEATS; NITRIC OXIDE SYNTHASE TYPE III; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, SINGLE NUCLEOTIDE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SEVERITY OF ILLNESS INDEX; SPIROMETRY; VENTRICULAR PRESSURE;

EID: 84862224525     PISSN: None     EISSN: 14712466     Source Type: Journal    
DOI: 10.1186/1471-2466-12-25     Document Type: Article

References (34)

1. Minai OA, Chaouat A, Adnot S. Pulmonary hypertension in COPD: epidemiology, significance, and management: pulmonary vascular disease: the global perspective. Chest 2010, 137(6 Suppl):39S-51S. 10.1378/chest.10-0087, 20522579.
2. Weitzenblum E, Sautegeau A, Ehrhart M, Mammosser M, Hirth C, Roegel E. Long-term course of pulmonary arterial pressure in chronic obstructive pulmonary disease. Am Rev Respir Dis 1984, 130(6):993-998.
3. Kessler R, Faller M, Weitzenblum E, Chaouat A, Aykut A, Ducolone A, Ehrhart M, Oswald-Mammosser M. "Natural history" of pulmonary hypertension in a series of 131 patients with chronic obstructive lung disease. Am J Respir Crit Care Med 2001, 164(2):219-224.
4. Jyothula S, Safdar Z. Update on pulmonary hypertension complicating chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis 2009, 4:351-363. 2754087, 19802350.
5. Chaouat A, Savale L, Chouaid C, Tu L, Sztrymf B, Canuet M, Maitre B, Housset B, Brandt C, Le CP, et al. Role for interleukin-6 in COPD-related pulmonary hypertension. Chest 2009, 136(3):678-687. 10.1378/chest.08-2420, 19349390.
6. Ulrich S, Hersberger M, Fischler M, Nussbaumer-Ochsner Y, Treder U, Russi EW, Speich R. Genetic polymorphisms of the serotonin transporter, but not the 2a receptor or nitric oxide synthetase, are associated with pulmonary hypertension in chronic obstructive pulmonary disease. Respiration; international review of thoracic diseases 2010, 79(4):288-295. 10.1159/000226243, 3417172, 22924030.
7. Castaldi PJ, Hersh CP, Reilly JJ, Silverman EK. Genetic associations with hypoxemia and pulmonary arterial pressure in COPD. Chest 2009, 135(3):737-744. 10.1378/chest.08-1993, 2906241, 19017876.
8. Sun LR, Wang C, Wu AQ, Yan BM, Li DM, Zhang JL, Wang GJ, Zhang Y, Li XQ, Zhang QZ. Gene polymorphism of the endothelial nitric oxide synthase enzyme and pulmonary hypertension in patient with chronic obstructive pulmonary disease. Zhonghua Jie He He Hu Xi Za Zhi 2008, 31(5):335-340.
9. Eddahibi S, Chaouat A, Tu L, Chouaid C, Weitzenblum E, Housset B, Maitre B, Adnot S. Interleukin-6 gene polymorphism confers susceptibility to pulmonary hypertension in chronic obstructive pulmonary disease. Proc Am Thorac Soc 2006, 3(6):475-476. 10.1513/pats.200603-037MS, 16921112.
10. Tkacova R, Joppa P, Stancak B, Salagovic J, Misikova S, Kalina I. The link between angiotensin-converting enzyme genotype and pulmonary artery pressure in patients with COPD. Wien Klin Wochenschr 2005, 117(5-6):210-214.
11. Ahsan A, Ram R, Baig MA, Pasha MA. ACE I allele and eNOS G allele crosstalk may have a role in chronic obstructive pulmonary disease. Clin Biochem 2004, 37(11):1037-1040. 10.1016/j.clinbiochem.2004.05.026, 15498534.
12. Kanazawa H, Tateishi Y, Yoshikawa J. Acute effects of nifedipine administration in pulmonary haemodynamics and oxygen delivery during exercise in patients with chronic obstructive pulmonary disease: implication of the angiotensin-converting enzyme gene polymorphisms. Clin Physiol Funct Imaging 2004, 24(4):224-228. 10.1111/j.1475-097X.2004.00552.x, 15233837.
13. Yildiz P, Oflaz H, Cine N, Erginel-Unaltuna N, Erzengin F, Yilmaz V. Gene polymorphisms of endothelial nitric oxide synthase enzyme associated with pulmonary hypertension in patients with COPD. Respir Med 2003, 97(12):1282-1288. 10.1016/j.rmed.2003.06.001, 14682408.
14. Eddahibi S, Chaouat A, Morrell N, Fadel E, Fuhrman C, Bugnet AS, Dartevelle P, Housset B, Hamon M, Weitzenblum E, et al. Polymorphism of the serotonin transporter gene and pulmonary hypertension in chronic obstructive pulmonary disease. Circulation 2003, 108(15):1839-1844. 10.1161/01.CIR.0000091409.53101.E8, 14530202.
15. Kanazawa H, Hirata K, Yoshikawa J. Effects of captopril administration on pulmonary haemodynamics and tissue oxygenation during exercise in ACE gene subtypes in patients with COPD: a preliminary study. Thorax 2003, 58(7):629-631. 10.1136/thorax.58.7.629, 1746721, 12832683.
16. Kanazawa H, Otsuka T, Hirata K, Yoshikawa J. Association between the angiotensin-converting enzyme gene polymorphisms and tissue oxygenation during exercise in patients with COPD. Chest 2002, 121(3):697-701. 10.1378/chest.121.3.697, 11888948.
17. Kanazawa H, Okamoto T, Hirata K, Yoshikawa J. Deletion polymorphisms in the angiotensin converting enzyme gene are associated with pulmonary hypertension evoked by exercise challenge in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000, 162(4 Pt 1):1235-1238.
18. van Suylen RJ, Wouters EF, Pennings HJ, Cheriex EC, van Pol PE, Ambergen AW, Vermelis AM, Daemen MJ. The DD genotype of the angiotensin converting enzyme gene is negatively associated with right ventricular hypertrophy in male patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999, 159(6):1791-1795.
19. Nakayama T, Soma M, Saito S, Honye J, Yajima J, Rahmutula D, Kaneko Y, Sato M, Uwabo J, Aoi N, et al. Association of a novel single nucleotide polymorphism of the prostacyclin synthase gene with myocardial infarction. Am Heart J 2002, 143(5):797-801. 10.1067/mhj.2002.122171, 12040339.
20. Watson CJ, Webb NJ, Bottomley MJ, Brenchley PE. Identification of polymorphisms within the vascular endothelial growth factor (VEGF) gene: correlation with variation in VEGF protein production. Cytokine 2000, 12(8):1232-1235. 10.1006/cyto.2000.0692, 10930302.
21. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease [www.goldcopd.com].
22. Miller MR, Crapo R, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Enright P, van der Grinten CP, Gustafsson P, et al. General considerations for lung function testing. Eur Respir J 2005, 26(1):153-161. 10.1183/09031936.05.00034505, 15994402.
23. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CP, Gustafsson P, et al. Standardisation of spirometry. Eur Respir J 2005, 26(2):319-338. 10.1183/09031936.05.00034805, 16055882.
24. Macintyre N, Crapo RO, Viegi G, Johnson DC, van der Grinten CP, Brusasco V, Burgos F, Casaburi R, Coates A, Enright P, et al. Standardisation of the single-breath determination of carbon monoxide uptake in the lung. Eur Respir J 2005, 26(4):720-735. 10.1183/09031936.05.00034905, 16204605.
25. Morris JF, Koski A, Johnson LC. Spirometric standards for healthy nonsmoking adults. Am Rev Respir Dis 1971, 103(1):57-67.
26. Cotes JE. Lung Function 1993, Blackwell Scientific Publications, London.
27. Celli BR, Thomas NE, Anderson JA, Ferguson GT, Jenkins CR, Jones PW, Vestbo J, Knobil K, Yates JC, Calverley PM. Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH study. Am J Respir Crit Care Med 2008, 178(4):332-338. 10.1164/rccm.200712-1869OC, 18511702.
28. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise JS, et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005, 18(12):1440-1463. 10.1016/j.echo.2005.10.005, 16376782.
29. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988, 16(3):1215. 10.1093/nar/16.3.1215, 334765, 3344216.
30. Dupont WD, Plummer WD. Power and sample size calculations. A review and computer program. Control Clin Trials 1990, 11(2):116-128. 10.1016/0197-2456(90)90005-M, 2161310.
31. Higham MA, Dawson D, Joshi J, Nihoyannopoulos P, Morrell NW. Utility of echocardiography in assessment of pulmonary hypertension secondary to COPD. Eur Respir J 2001, 17(3):350-355. 10.1183/09031936.01.17303500, 11405510.
32. Wang XL, Mahaney MC, Sim AS, Wang J, Blangero J, Almasy L, Badenhop RB, Wilcken DE. Genetic contribution of the endothelial constitutive nitric oxide synthase gene to plasma nitric oxide levels. Arterioscler Thromb Vasc Biol 1997, 17(11):3147-3153. 10.1161/01.ATV.17.11.3147, 9409304.
33. Tsukada T, Yokoyama K, Arai T, Takemoto F, Hara S, Yamada A, Kawaguchi Y, Hosoya T, Igari J. Evidence of association of the ecNOS gene polymorphism with plasma NO metabolite levels in humans. Biochem Biophys Res Commun 1998, 245(1):190-193. 10.1006/bbrc.1998.8267, 9535806.
34. Busquets X, MacFarlane NG, Heine-Suner D, Morla M, Torres-Juan L, Iglesias A, Llado J, Sauleda J, Agusti AG. Angiotensin-converting-enzyme gene polymorphisms, smoking and chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis 2007, 2(3):329-334. 2695206, 18229571.